PMV Pharmaceuticals Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
PMV Pharmaceuticals Inc
Did you know?
Capital expenditures decreased by 100% from FY24 to FY25.
Current Price
$1.43
+1.79%Profile
Valuation (TTM)
Market Cap$74.50M
P/E-0.96
EV—
P/B0.71
Shares Out52.28M
P/Sales—
Revenue$0.00
EV/EBITDA—
PMVP (PMVP) — Earnings Call Transcripts
No transcripts available yet
No earnings call transcripts are available for PMVP yet. Check back after the next earnings report.
← Back to PMVP overview